{"name":"AnHeart Therapeutics Inc.","slug":"anheart-therapeutics-inc","ticker":"","exchange":"","domain":"anheart.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBYR1d4bWh1ejJoanlmeGstQktPeXVEeHJhTXlEVjBxRlh0NjNGcC1rYnR2UThEdmdpdVpCcFlWQWQzZTBsQjJGVlB3QWJ4NVQyZF9zYnIyZWRSdFBIUXdN?oc=5","date":"2026-02-04","type":"trial","source":"Nature","summary":"Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial - Nature","headline":"Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTFBGRmlsY25ZUVlFejlMMkE2aVVJVTJLdFVBTF9PRVY4eU4xb2VyeFdaTnVvRExrY2x0UHUyWG5FaDdCR2hDcXZ1SU9rcGVhSHR6am03MzdlX0VVblhnQUE?oc=5","date":"2025-07-10","type":"pipeline","source":"Oncodaily","summary":"Taletrectinib (Ibtrozi) 2025 Updates: Uses in Cancer, Side effects, Dosage, Expectations and more - Oncodaily","headline":"Taletrectinib (Ibtrozi) 2025 Updates: Uses in Cancer, Side effects, Dosage, Expectations and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPQjNvZm4zM0V6Z3BYUGJrVVYyTFJ4dktJdzNVdWlSQXQwSmMxQ1JDRkF1MWtjYnZfWlkzclJ5d00zNTdXSDZkVlFtVzgzdkl2VkduWFpLR3FYUWdhVGN1RHh3RXkwaVRHZFh1aDhUS2J6aUNuUG9QOHc0VkJIS0ZIV2NkcnVYQkRpOU5oUVQ1cDYybnAyRnlocEFn?oc=5","date":"2025-03-06","type":"pipeline","source":"TradingView","summary":"Nuvation Bio Inc. SEC 10-K Report - TradingView","headline":"Nuvation Bio Inc. SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPRDkzdVdtZjRvWXF3bXhfbkhMY2ZraXlxNXlVc1VsblF1cGp3eVkzMUFQem1MYWdmOGgzbXlURVI0cDJSTlV5UkVjZTNjSkhqbjJqUEJCMGgxNlI3SHVaa0tNOGU2ZE1rZ0hwcURVMS1FcUFFVHJLTktVcTFnWkVxTW02WHVsS005ZTlib3dVVmU5ZDdkUGF1YXlwUlpkRHFHYk9aVXhJb1pQbkk?oc=5","date":"2025-02-12","type":"pipeline","source":"Investing.com","summary":"Nuvation Bio executive departs after key milestones - Investing.com","headline":"Nuvation Bio executive departs after key milestones","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPd1E4SzdmSjF5STRoVjhNT1N6RDBGUlFNM0dqbnVFRlFPNk9XSzFGQ25qYzg4OEk2Ym0wcFdZUEJ4MVlTN3BILWU4Tm92R1dTc01ILUdlbGF1WHF6dTM0VHJJM2hvZmt0b1N3T1pXMUVVMmNxRUJBdXBrMS1JbklscHkyTWVZdjVtQjctNkk4XzlhXzQ?oc=5","date":"2024-04-07","type":"pipeline","source":"Table.Briefings","summary":"Takeover shows interest in Chinese biotech companies - Table.Briefings","headline":"Takeover shows interest in Chinese biotech companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOcXNyNXd3UVhoWHY1ME1YNFNfbkozZl9Oa1FtSW1PZm5rU0IyVDhLSzgtY0FCTERieERJS1pEa2VoREdBTnVUeExUTG9WV1gweEoyd3VnYmtlRmEyeVI5bUNmUDFhLVkydGtBN1hSbzAzYW11U0lVTm9NZThVbmZlN1BDRnpSZw?oc=5","date":"2024-03-26","type":"deal","source":"Pharmaceutical Technology","summary":"Nuvation Bio to acquire AnHeart to form global oncology company - Pharmaceutical Technology","headline":"Nuvation Bio to acquire AnHeart to form global oncology company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNeFRQWllPbWJabk1tZ1pVMVFSMUJhTE9tWjFBcjFJZE1RU1k3ZW14cC1ZY3RPT1pFQ2lnZnFEd0lJSGRSSmVITDhMYVV0WWwzRlkxTmRING5yLU5TWWpnT19xckE4NWFMbGdNX3RELUhmTmhqX2czcC1QQjQzRGZsM1p6bw?oc=5","date":"2024-03-26","type":"deal","source":"pharmaphorum","summary":"Nuvation Bio nears commercial stage with AnHeart buy - pharmaphorum","headline":"Nuvation Bio nears commercial stage with AnHeart buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQTFBqQTJ0ZnA4bHpwZTQydjV0UjBJaGpvaENJOUtUTHJyVGlFZl9MT0ZhTlFpTVVpS05hM1dNMF9DVWc5emxWbUpuQkFXdGJPRHB2QU1FYWNRVEU1bTVJYmQtTFRsQmt1bk91dFJMeGhLQ1lQLUlnbmF6QmFrdTRsR2psTm9HeTMxcVBrZHNYTTFBenR2c1FxYk42enNOVDg?oc=5","date":"2024-03-26","type":"deal","source":"BioWorld News","summary":"Nuvation to buy Anheart, cancer pipeline in all-stock deal - BioWorld News","headline":"Nuvation to buy Anheart, cancer pipeline in all-stock deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxPZHRjSEg4VUVIWkY3MXNRVnRhTk12aG5WTFJPWmdvVHkwR01PcjZZcE9LanlyMF9INC1idUhKWlYwZnNCTFVzLUNnUks4MUxKXzJiSC1sb3huZ3BPVnVTQ1ROeVRYWk5Wb1ltRmI1TFh4U01yeFRUdnUwT0tWUXdwci0yODNxYk5lT2dETElad0d0UXB5dE5lN0VkS0tlSlFudVViQXRHaHVucTlHU3duM2cxM1ZRWGpHTzItRFZOdHpnY1RsVW9LU0xqZTA5TGNPVHJjaEJSVW5Dc2RsTE5wb0JDQ0otS01HTW5vNjMwbV8weDhfM2hKNWVrM2xKTHpfSU9peUt5Ymp2bXF4d1JGXzh6a0p4cU0zdUhhTkhKRlRHT3JHX0Fmal9xSVRMN1pTYW41eUVxZU1LcFBzd1pvdmpMaGY5WlE?oc=5","date":"2024-03-04","type":"pipeline","source":"businesswire.com","summary":"AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer - businesswire.com","headline":"AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for F","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNZk1SMG1TcGIxd2dSVFdndlpLU1Nkdk9JNjdJTFEwR0hoamU4M0JSWURJc3g5eWtFSG03WDRUS3hUYTVuMEt6SkxIS1dFSTZUVXNxNnR4QVJzNEx2NmRMSlBudFNiYUt5QlpMUW5SeHNYaV9JbGJYSTRLd2NJWnA4UDJISS1CZ0JwOU9PbEZDVWZLempJdlJHQWZFLWJCUTRnNjA4cktlaEZnMU5CbXZQSUxwdjRnMnUxbXlsUQ?oc=5","date":"2023-09-28","type":"pipeline","source":"citybiz","summary":"AnHeart Therapeutics Appoints Charlotte Arnold as Chief Corporate Affairs Officer - citybiz","headline":"AnHeart Therapeutics Appoints Charlotte Arnold as Chief Corporate Affairs Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBxYTV1TVFsVjhWQ3lxdXpKTlB0eEFBOGlYOUJESWkyWFNyQUhoaGItQWhCRVJlM0pVV2VXcDBSdlhmWkd6RVplOXFxN0tCZVd6akh0dVphNml6VC0zOF9ySlI3dFlMSHNqS2lQdmhzQV9kTWI2V01jRUln?oc=5","date":"2023-09-08","type":"trial","source":"Clinical Trials Arena","summary":"AnHeart doses first patient in glioma therapy trial - Clinical Trials Arena","headline":"AnHeart doses first patient in glioma therapy trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNYk0wZkd1Qzl4YWtZVkpSZml2djhlSFRvalZ1MG5pTS1wMlJlSndlTlNzWFYtczdLOUhldVhZbWdNb2h2UmtxUU0yeExPdnJhSEpRZlRjTHdQNFhpcmxwdWcxSkQ3enhHTTZJZmg5OVFMdVpySDFndjB2TGpXVFZqX1JfVEU0cml5WTkxU2g4eWYzUDRaN214WVB5TQ?oc=5","date":"2023-04-03","type":"pipeline","source":"BioSpace","summary":"AnHeart Therapeutics Appoints Edward Lang Jr. as Chief Business Officer - BioSpace","headline":"AnHeart Therapeutics Appoints Edward Lang Jr. as Chief Business Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}